A novel l-lysine based multifunctional crosslinker family was developed and utilized to fabricate a 100% pure poly(ester amide) (PEA) hydrogel with unique structure via a novel gelation strategy in a single and rapid step. Enzyme triggered biodegradation was utilized to turn the resultant macro hydrogel into abundant microgels with a 3 micron size in the early stage. Nanogels of 50 nm in diameter were then formed after 8 days of biodegradation in the enzyme solution. The enzyme degradation of doxorubicin (DOX) loaded macro-gel indicated that the micro and nano gels containing DOX could be obtained using the same strategy while retaining their sustained drug release performance. This study reports a new biocompatible and biodegradable crosslinker and hydrogel system, and illustrates a new nanotechnology capable of controllably producing nanogels using the enzymatic degradation of macro hydrogels.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: